Wickham Striae (Lichen Planus)
What is Wickham Striae (Lichen Planus)?
Wickham striae are the characteristic, fine, whiteâlacy lines or dots that appear on the surface of lesions caused by lichen planus, an inflammatory condition that targets the skin, mucous membranes, hair follicles and nails. The striae are most visible on the âflatâtoppedâ purple papules that typically develop on the wrists, shins, lower back, and oral cavity. While the name Wickham striae refers specifically to this surface pattern, it is most often used interchangeably with the term lichen planus in patientâfocused literature.
Lichen planus is considered an autoimmuneâmediated disease: the bodyâs immune system mistakenly attacks basal keratinocytes (skin cells) leading to inflammation and the classic lesions. The exact trigger is unknown, but a combination of genetic susceptibility, viral infections, medications, and chronic irritants is thought to play a role [1][2].
Common Causes
Although the precise cause of lichen planus remains elusive, several factors have been linked to its onset or exacerbation. Below are the most frequently reported associations:
- Hepatitis C infection â one of the strongest epidemiological links (up to 30% of patients in some series) [3].
- Medications â especially antihypertensives (ACE inhibitors, thiazide diuretics), nonâsteroidal antiâinflammatory drugs (NSAIDs), and antimalarials.
- Dental materials â metals such as amalgam, gold, and nickel can trigger oral lichen planus.
- Viral infections â herpesâsimplex virus, human papillomavirus (HPV), and EpsteinâBarr virus have been implicated.
- Genetic predisposition â certain HLAâDQ alleles appear more often in affected individuals.
- Stress and hormonal changes â emotional stress or pregnancy may precipitate flares.
- Contact irritants â topical dyes, fragrances, or chronic scratching.
- Autoimmune diseases â such as thyroiditis, lupus erythematosus, or rheumatoid arthritis, can coexist.
- Heavy metal exposure â arsenic, lead, and mercury have been reported in isolated case series.
- Sunlight (UV) exposure â especially in individuals with photosensitive skin types, may worsen cutaneous lesions.
Associated Symptoms
Patients with Wickham striae often notice other clinical features that accompany the classic papules:
- Itching (pruritus) â the most common complaint; can be severe enough to disrupt sleep.
- Oral discomfort â burning or soreness on the tongue, inner cheeks, or gums (oral lichen planus).
- Nail changes â thinning, ridging, splitting, or the âpterygiumâ where skin grows forward from the nail base.
- Hair loss â scarring alopecia on the scalp when follicles are involved (lichen planopilaris).
- Genital lesions â erosive or erosiveâulcerative plaques on the vulva or penis, sometimes confused with sexually transmitted infections.
- Whiteâlacy patches â especially on the buccal mucosa, often mistaken for candidiasis.
- Painful erosions â especially after trauma (e.g., brushing teeth), leading to secondary infection.
When to See a Doctor
Because lichen planus can affect multiple body sites and may signal an underlying systemic condition, prompt medical evaluation is essential when any of the following occur:
- New, persistent rash or oral lesions that do not resolve within two weeks.
- Severe itching that interferes with daily activities or sleep.
- Swelling, blistering, or ulceration of the mouth, genital area, or eyes.
- Visible nail changes or sudden hair loss.
- Signs of infection (increased redness, warmth, pus, fever).
- Known hepatitis C or other chronic viral infection without prior skinâcheck.
- Any suspicion that a medication may be triggering the rash.
Diagnosis
Diagnosing Wickham striae / lichen planus involves a combination of clinical observation and, when needed, laboratory testing.
Clinical Exam
- Identification of the classic violaceous, flatâtopped papules with Wickham striae.
- Examination of oral cavity, nails, scalp, and genitalia for associated lesions.
- Documentation of distribution pattern (typically wrists, ankles, lower back, and mucosa).
Skin or Mucosal Biopsy
When the diagnosis is uncertain, a 4âmm punch biopsy is taken. Histopathology typically shows:
- Bandâlike lymphocytic infiltrate at the dermalâepidermal junction.
- Degeneration of basal keratinocytes (âsawâtoothâ rete ridges).
- Hypergranulosis and Civatte bodies (necrotic keratinocytes).
Additional Tests
- Hepatitis C serology â recommended for all newly diagnosed patients.
- Complete blood count (CBC) and liver function tests if systemic medication is considered.
- Patch testing if a contact allergen is suspected.
Treatment Options
Therapy is aimed at relieving symptoms, limiting lesion spread, and preventing complications. Treatment plans are individualized based on location, severity, and patient comorbidities.
Topical Therapies
- Highâpotency corticosteroids (e.g., clobetasol 0.05% ointment) â firstâline for cutaneous lesions; apply once daily for 2â4 weeks.
- Topical calcineurin inhibitors (tacrolimus 0.1% or pimecrolimus 1%) â useful for oral or genital mucosa where steroids may cause thinning.
- Retinoids (tazarotene 0.05% cream) â helpful for hyperkeratotic lesions.
Systemic Medications
- Oral corticosteroids (prednisone 0.5â1 mg/kg) â reserved for extensive or rapidly progressive disease.
- Antimalarials (hydroxychloroquine 200â400âŻmg daily) â effective for mucosal and cutaneous forms; monitor retinal toxicity.
- Immunosuppressants (mycophenolate mofetil, azathioprine) â for refractory cases.
- Biologic agents â emerging data support the use of dupilumab or secukinumab for recalcitrant disease.
Phototherapy
Narrowâband UVB or psoralenâUVA (PUVA) can improve widespread plaques, especially on the trunk and limbs. Treatment is usually administered 2â3 times per week for 8â12 weeks.
Supportive & Home Care
- Gentle skin care â fragranceâfree moisturizers to reduce barrier disruption.
- Avoidance of known triggers (e.g., specific dental alloys, certain medications).
- Use of soft toothbrushes and nonâalcoholic mouth rinses for oral lesions.
- Cool compresses or oatmeal baths to soothe itching.
- Stressâreduction techniques (mindfulness, yoga) as psychological stress can precipitate flares.
Prevention Tips
While it is impossible to prevent every episode, the following strategies can lower the risk of new lesions or worsening of existing disease:
- Maintain regular dental checkâups; ask for metalâfree restorations if you have oral lichen planus.
- Report new medications to your doctor; a pharmacist can help identify drugs associated with lichenoid reactions.
- Practice good sun protection â broadâspectrum sunscreen SPFâŻ30+ and protective clothing.
- Keep nails trimmed short to avoid trauma that could trigger nail involvement.
- Manage chronic hepatitis C or other viral infections under specialist care.
- Adopt a balanced diet rich in antioxidants (fruits, vegetables) which may help modulate immune response.
- Quit smoking; tobacco has been linked with more severe oral lichen planus.
Emergency Warning Signs
If you experience any of the following, seek immediate medical attention (go to the emergency department or call 911):
- Rapidly spreading blistering or ulceration accompanied by high fever (>38.5âŻÂ°C / 101âŻÂ°F).
- Severe throat pain or difficulty swallowing that threatens airway patency.
- Sudden, intense pain in the eyes with vision changes (possible ocular involvement).
- Signs of secondary bacterial infection â increasing redness, warmth, pus, or foul odor from a lesion.
- Unexplained swelling of the lips, tongue, or face (possible angioedema).
References
- Mayo Clinic. Lichen planus: Symptoms and causes. https://www.mayoclinic.org. Accessed June 2026.
- National Center for Biotechnology Information (NCBI). Pathogenesis of lichen planus. https://www.ncbi.nlm.nih.gov.
- World Health Organization (WHO). Hepatitis C and extraâhepatic manifestations. https://www.who.int. 2023.
- Cleveland Clinic. Lichen planus treatment overview. https://my.clevelandclinic.org. Updated 2025.
- Centers for Disease Control and Prevention (CDC). Managing medicationâinduced lichenoid eruptions. https://www.cdc.gov.